Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tulika Chatterjee

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Diabetes Investigation|September 12, 2023
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD studyTulika Chatterjee, Naveen Ravichandran, Narmadha Nair, et al.
Rheumatology International|December 7, 2023
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) GroupSuhrud Panchawagh, Naveen Ravichandran, Bhupen Barman, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD studyParikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
Modern Rheumatology|September 28, 2023
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD datasetAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Rheumatology (Oxford, England)|August 3, 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-surveyAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology International|June 14, 2023
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-surveySilvia Grignaschi, Minchul Kim, Giovanni Zanframundo, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|October 10, 2025
Discordance in Patient and Physician's Perception of Disease Activity Among Idiopathic Inflammatory Myopathy Patients: Insights From the COVAD StudyRudra P Goswami, Parikshit Sen, Zoha Zahid Fazal, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Diabetes Investigation|September 12, 2023
Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD studyTulika Chatterjee, Naveen Ravichandran, Narmadha Nair, et al.
Rheumatology International|December 7, 2023
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) GroupSuhrud Panchawagh, Naveen Ravichandran, Bhupen Barman, et al.
Rheumatology International|September 15, 2023
Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohortSuhrud Panchawagh, Doskaliuk Bohdana, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|June 17, 2022
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD studyParikshit Sen, Naveen Ravichandran, Arvind Nune, et al.
Modern Rheumatology|September 28, 2023
Gender differences in patient experience in idiopathic inflammatory myopathies: Subanalysis from the COVAD datasetAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology (Oxford, England)|May 25, 2023
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey studyNelly Ziade, Marc Aoude, Ihsane Hmamouchi, et al.
Rheumatology (Oxford, England)|August 3, 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-surveyAkira Yoshida, Minchul Kim, Masataka Kuwana, et al.
Rheumatology International|June 14, 2023
High fatigue scores in patients with idiopathic inflammatory myopathies: a multigroup comparative study from the COVAD e-surveySilvia Grignaschi, Minchul Kim, Giovanni Zanframundo, et al.
Rheumatology International|March 31, 2023
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) surveyR Naveen, Darpan R Thakare, Masataka Kuwana, et al.
International Journal of Rheumatic Diseases|October 10, 2025
Discordance in Patient and Physician's Perception of Disease Activity Among Idiopathic Inflammatory Myopathy Patients: Insights From the COVAD StudyRudra P Goswami, Parikshit Sen, Zoha Zahid Fazal, et al.
Pageof 7